key: cord-0843267-ofuwlu1z authors: Liu, Qiang; Gerdts, Volker title: Transmissible Gastroenteritis Virus of Pigs and Porcine Epidemic Diarrhea Virus date: 2019-12-31 journal: Reference Module in Life Sciences DOI: 10.1016/b978-0-12-809633-8.20928-x sha: 0428e40ab214b4133e308633148ef1e469519d3f doc_id: 843267 cord_uid: ofuwlu1z Abstract TGEV and PEDV are porcine coronaviruses with typical coronavirus virion structures and replication cycles. Both viruses cause diarrhea in pigs with similar clinical symptoms. Disease severity is inversely related to the age of animals. While TGEV infections are currently under control, recent emergence of virulent PEDV strains results in significant mortality. No effective treatments are available once animals are infected. Detection of viral antigen and/or genomic RNA is required for diagnosis. Prevention measures include enhanced biosecurity and vaccination with the latter being the most effective approach. Commercial vaccines for both viruses are available and numerous experimental vaccines are in development. The life cycles of TGEV and PEDV consist of virion attachment and entry, viral RNA translation, viral RNA replication and transcription, virion assembly and release (Fig. 2) . Virion attachment to a host cell requires the interaction between viral S protein with cellular receptors. Aminopeptidase N (APN) is a major receptor for TGEV. However, whether APN is an essential receptor for PEDV is debatable. PEDV S protein can bind to sialic acid on the cell surface that may mediate virion attachment. After receptor binding, the S protein undergoes proteolytic cleavage that in turn induces membrane fusion and virion entry. Viral RNA with a 5′ cap structure and a 3′ polyadenylated tail serves as an mRNA that is translated by cellular translation machinery to generate viral replicase proteins pp1a and pp1ab. Replication and transcription complexes formed by these proteins produce both genomic and subgenomic progeny RNA species. Structural and accessory proteins are translated from subgenomic RNAs. Nucleocapsids formed by the N protein and progeny viral genomic RNA are enveloped in the endoplasmic reticulum -Golgi intermediate compartment with the involvement of S, E, and M proteins. The assembled virions are transported to the cell surface and released. Epidemiology TGEV, first described in 1946 in USA, has been detected all over the world. PEDV was first isolated in 1978 in Belgium and is widespread in Europe and Asia ever since. The appearance of PEDV in North America was reported in 2013 where the virus continues to circulate in swine herds and there is a potential for new PEDV strains to emerge. Both TGEV and PEDV cause enteritis in pigs with very similar clinical symptoms. Major clinical signs include vomiting, watery diarrhea, dehydration, and weight loss. The mortality rate can reach greater than 90% and is inversely related to the age of pigs. Penetration and uncoating occur after the S protein-mediated fusion of the viral envelope with the plasma membrane. Following disassembly, the viral genome is released into the cytoplasm and immediately translated to yield replicases ppla and pp1ab. These polyproteins are proteolytically cleaved into 16 nsps comprising the replication and transcription complex (RTC) that first engages in the minus-strand RNA synthesis using genomic RNA. Both full-and sub genomic (sg)-length minus strands are produced and used to synthesize full-length genomic RNA and sg mRNAs. Each sg mRNA is translated to yield only the protein encoded by the 5'-most ORF of the sg mRNA. The envelope S, E, and M proteins are inserted in the ER and anchored in the Golgi apparatus. The N protein interacts with newly synthesized genomic RNA to form helical RNP complexes. The progeny virus is assembled by budding of the preformed RNP at the ER-Golgi intermediate compartment (ERGIC) and then released by the exocytosis-like fusion of smoothwalled, virion-containing vesicles with the plasma membrane. Reproduced from Lee, C., 2015. Porcine epidemic diarrhea virus: An emerging and re-emerging epizootic swine virus. Virology Journal, 12, 193, under BioMed Central license agreement. Villous enterocytes in small and large intestine are the major target cells of TGEV and PEDV infections. Viral infection causes cell death that results in villous atrophy followed by malabsorption, diarrhea, dehydration, anorexia, and eventually animal death. The molecular mechanisms for pathogenesis are not very well understood. There is evidence to suggest that viral proteins, such as spike and ORF3 proteins may affect viral virulence. At the molecular level, TGEV and PEDV have been shown to modulate multiple cellular processes/pathways including endoplasmic reticulum stress, cell cycle, and mitogen-activated protein kinase signaling. Because clinical signs cannot distinguish between TGEV and PEDV infections, additional assays are required for diagnosis. Common diagnostic assays include viral antigen detection by histoimmunochemistry and enzyme-linked immuosorbent assay (ELISA), viral RNA detection and genotyping by PCR and sequencing, virus isolation by cell culture, as well as antibody detection by serology. There is no specific treatment for TGEV and PEDV infections. Enhanced biosecurity procedures are a general means to contain the spread and prevent the entrance of viral infection in pig farms, but vaccination represents the most effective way in preventing TGEV and PEDV outbreaks. Because of high mortality in piglets, it has become a common practice to vaccinate sows in order to transfer lactogenic immunity to protect piglets from TGEV and PEDV infections. Live attenuated and inactivated virus vaccines have been developed for both TGEV and PEDV. Since the spike protein is the major immunogen, numerous technologies have been employed to express the spike protein. These include DNA vaccine, vectored vaccine, subunit vaccine, and dendritic cell-based vaccine. Experimental and commercial TGEV and PEDV vaccines are listed in Table 1 . Life Sciences Transmissible gastroenteritis in pigs in south east Spain: Prevalence and factors associated with infection Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV Porcine epidemic diarrhea virus: An overview of current virological and serological diagnostic methods Complete sequence (20 kilobases) of the polyprotein-encoding gene 1 of transmissible gastroenteritis virus Coronaviruses: An overview of their replication and pathogenesis Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses Lesions of the gastrointestinal tract of pigs infected with transmissible gastroenteritis Detection, sequence analysis, and antibody prevalence of porcine deltacoronavirus in Taiwan Molecular characterization and phylogenetic analysis of transmissible gastroenteritis virus HX strain isolated from China Aminopeptidase-N-independent entry of porcine epidemic diarrhea virus into Vero or porcine small intestine epithelial cells Porcine epidemic diarrhea virus infection: Etiology, epidemiology, pathogenesis and immunoprophylaxis Completion of the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence Lactogenic immunity and vaccines for porcine epidemic diarrhea virus (PEDV): Historical and current concepts Porcine epidemic diarrhea virus: An emerging and re-emerging epizootic swine virus Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry Cellular entry of the porcine epidemic diarrhea virus Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains Prevalence of antibodies against transmissible gastroenteritis virus and porcine respiratory coronavirus among pigs in six regions in Japan Viral and cellular mRNA translation in coronavirus-infected cells Swine enteric coronavirus disease: A review of 4 years with porcine epidemic diarrhoea virus and porcine deltacoronavirus in the United States and Canada A new coronavirus-like particle associated with diarrhea in swine First retrospective studies with etiological confirmation of porcine transmissible gastroenteritis virus infection in Argentina Full-length genome sequences of porcine epidemic diarrhoea virus strain CV777; Use of NGS to analyse genomic and sub-genomic RNAs The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine Porcine aminopeptidase N is not a cellular receptor of porcine epidemic diarrhea virus, but promotes its infectivity via aminopeptidase activity Porcine epidemic diarrhea: A review of current epidemiology and available vaccines Emergence of Porcine epidemic diarrhea virus in the United States: Clinical signs, lesions, and viral genomic sequences Vaccination of sows with a dendritic cell-targeted porcine epidemic diarrhea virus S1 protein-based candidate vaccine reduced viral shedding but exacerbated gross pathological lesions in suckling neonatal piglets Prevalence of coronavirus antibodies in Iowa swine Virulence factors in porcine coronaviruses and vaccine design